Huberman Lab
Dr. Peter Attia: Supplements for Longevity & Their Efficacy
Dr. Peter Attia
But I think Joan Manick and Lloyd Clickstein, when they published that paper in 2014 using everolimus, where they took a group of 65-year-olds and randomized them to either a placebo or different doses and dosing schedules of everolimus, found an enhanced immunity in response to an influenza vaccine, which again was, for me, that was the turning point. That's when rapamycin went from
0
💬
0
Comments
Log in to comment.
There are no comments yet.